Summary:
ICON Development Solutions is conducting a research study for adults with Type 2 Diabetes, ages 18-65. This study is being done to test the safety and tolerability of an investigational drug for Type 2 Diabetes. The study drug will be administered by subcutaneous injections.
Vital signs, ECGs, physical examinations and pregnancy, drug and alcohol screens will be performed. Blood and urine samples will also be obtained during this study.
Participants will complete:
1 screening visit
2 non-consecutive stays at the clinic for a total of 11 overnights
12 outpatient study visits
2 telephone calls
To determine if you fully qualify, it will be necessary to obtain blood samples after an 8 hour fast. You will need to provide medical records as part of the screening process for this study.
Qualified participants may be compensated for time and travel depending upon the assigned group.